1069-66-5CCCC(CCC)C(=O)O.[Na]RGZUPIWJTSGERU-UHFFFAOYSA-NSee also: Valproic Acid (annotation moved to); Sodium (annotation moved to); Divalproex Sodium (annotation moved to) ... View More ...
1069-66-5、76584-70-8Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
DescriptionSodium Valproate (1069-66-5) is a histone deacetylase inhibitor (IC50 = 400μM).1 Demonstrates neuroprotective, anticancer, and anti-inflammatory activity.2 Inhibits Aβ production, reduced neuritic plaque formation, and improved memory deficits in Alzheimer’s mouse models.3 Improves stem cell reprogramming efficiency and enables efficient induction of pluripotency without introduction of the oncogene c-Myc.4 Clinically useful anticonvulsant.
UsesAntiepileptic; increases levels of GABA in the brain
Usesantibacterial
UsesAnticonvulsant
General DescriptionA cell-permeable, short-chained fatty acid that inhibits histone deacetylase activity (IC50 = 400 μM for HDAC1). Induces differentiation and inhibits proliferation of cell lines derived from human malignant gliomas. At therapeutic levels (350 μM-1.04 mM), causes inositol depletion, inhibits both GSK-3α and -3β, activates the ERK pathway, and produces neurotropic effects. Has been used as an anti-epileptic agent. Also reported to stimulate peroxisome proliferator-activated receptor (PPAR) activity. Displays a potent teratogenic activity in humans and rodent models.
DefinitionChEBI: The sodium salt of valproic acid.
Try another role filter or search by structure.